Researchers examine unanticipated benefits of GLP-1 medications

GLP-1 receptor agonists and dual agonists person transformed the attraction of obesity and different metabolic diseases, and a caller editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and Dr. Adam Gilden of the University of Colorado examines what scientists are learning arsenic these medications scope millions of people.